good point re tax losses and market cap. the other side of buying losers is that unless you have a plan to profitability,you are buying a liability that will be a drag on the P&L.
Has BUBs ever turned a profit? have the BUBs issues with their former CEO been resolved? is there a risk of adverse publicity and litigation? maybe there are reasons why it's market cap is $100m.
I would rather see 100m.spent on marketing to the elderly/US FDA, US marketing and the release of new products ie the recent new formula release announcement
if Nestle etc pick up BUBs they will have a drain on their P&L and not much to show for it. Nestle market share in China is way behind A2M. Nestle is better off buying out A2M and actually getting to top 5 spot in China
Ann: 1H24 Results Presentation, page-72
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.130(1.96%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.77 | $6.63 | $10.00M | 1.485M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2420 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 37726 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |